Axsome to Present New Sunosi Data at SLEEP 2023
Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023. The presentations include data from the SHARP (Solriamfetol’s Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled) study in patients with excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA), demonstrating sustained improvement with Sunosi on measures of cognition…